NO754417L - - Google Patents
Info
- Publication number
- NO754417L NO754417L NO754417A NO754417A NO754417L NO 754417 L NO754417 L NO 754417L NO 754417 A NO754417 A NO 754417A NO 754417 A NO754417 A NO 754417A NO 754417 L NO754417 L NO 754417L
- Authority
- NO
- Norway
- Prior art keywords
- carbon atoms
- group
- formula
- separated
- compounds
- Prior art date
Links
- 125000004432 carbon atom Chemical group C* 0.000 claims description 74
- 150000001875 compounds Chemical class 0.000 claims description 57
- 239000002253 acid Substances 0.000 claims description 24
- 229910052757 nitrogen Inorganic materials 0.000 claims description 23
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 23
- 125000000217 alkyl group Chemical group 0.000 claims description 22
- 239000001257 hydrogen Substances 0.000 claims description 20
- 229910052739 hydrogen Inorganic materials 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 13
- 238000002360 preparation method Methods 0.000 claims description 12
- 150000003839 salts Chemical class 0.000 claims description 12
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims description 11
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 10
- 229910052799 carbon Inorganic materials 0.000 claims description 10
- 150000002431 hydrogen Chemical class 0.000 claims description 10
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 9
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 9
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 7
- 125000005078 alkoxycarbonylalkyl group Chemical group 0.000 claims description 6
- 125000005188 oxoalkyl group Chemical group 0.000 claims description 6
- 125000001424 substituent group Chemical group 0.000 claims description 5
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 4
- 125000005041 acyloxyalkyl group Chemical group 0.000 claims description 4
- 239000000460 chlorine Substances 0.000 claims description 4
- 229910052801 chlorine Inorganic materials 0.000 claims description 4
- 125000003545 alkoxy group Chemical group 0.000 claims description 3
- 125000002947 alkylene group Chemical group 0.000 claims description 3
- 229910052736 halogen Inorganic materials 0.000 claims description 3
- 150000002367 halogens Chemical class 0.000 claims description 3
- 125000002252 acyl group Chemical group 0.000 claims description 2
- 125000004448 alkyl carbonyl group Chemical group 0.000 claims description 2
- 125000005429 oxyalkyl group Chemical group 0.000 claims description 2
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 2
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims description 2
- 238000006243 chemical reaction Methods 0.000 description 21
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- -1 alkanoyl radical Chemical class 0.000 description 11
- 239000000243 solution Substances 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- 239000011541 reaction mixture Substances 0.000 description 8
- 230000002829 reductive effect Effects 0.000 description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 5
- 230000029936 alkylation Effects 0.000 description 5
- 238000005804 alkylation reaction Methods 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000003960 organic solvent Substances 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 150000007524 organic acids Chemical class 0.000 description 4
- KJIFKLIQANRMOU-UHFFFAOYSA-N oxidanium;4-methylbenzenesulfonate Chemical compound O.CC1=CC=C(S(O)(=O)=O)C=C1 KJIFKLIQANRMOU-UHFFFAOYSA-N 0.000 description 4
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 239000002841 Lewis acid Substances 0.000 description 3
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical class C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 150000007517 lewis acids Chemical class 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 150000007522 mineralic acids Chemical class 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 235000005985 organic acids Nutrition 0.000 description 3
- 239000012074 organic phase Substances 0.000 description 3
- 238000005932 reductive alkylation reaction Methods 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 description 2
- JWHDENUPJBYDPO-UHFFFAOYSA-N 2h-cyclohepta[e][1]benzothiole Chemical group C1=CC=CC=C2C3=CCSC3=CC=C21 JWHDENUPJBYDPO-UHFFFAOYSA-N 0.000 description 2
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 150000008065 acid anhydrides Chemical class 0.000 description 2
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 125000005243 carbonyl alkyl group Chemical group 0.000 description 2
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 2
- BGTOWKSIORTVQH-UHFFFAOYSA-N cyclopentanone Chemical compound O=C1CCCC1 BGTOWKSIORTVQH-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 150000004820 halides Chemical class 0.000 description 2
- 125000000468 ketone group Chemical group 0.000 description 2
- 239000012280 lithium aluminium hydride Substances 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 239000000155 melt Substances 0.000 description 2
- 150000002894 organic compounds Chemical class 0.000 description 2
- 150000004885 piperazines Chemical class 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 238000006722 reduction reaction Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 229940066771 systemic antihistamines piperazine derivative Drugs 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- PVMCQBPJKPMOKM-UHFFFAOYSA-N 1-cyclopentylpiperazine Chemical compound C1CCCC1N1CCNCC1 PVMCQBPJKPMOKM-UHFFFAOYSA-N 0.000 description 1
- NAMYKGVDVNBCFQ-UHFFFAOYSA-N 2-bromopropane Chemical compound CC(C)Br NAMYKGVDVNBCFQ-UHFFFAOYSA-N 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- QOXOZONBQWIKDA-UHFFFAOYSA-N 3-hydroxypropyl Chemical group [CH2]CCO QOXOZONBQWIKDA-UHFFFAOYSA-N 0.000 description 1
- QISOBCMNUJQOJU-UHFFFAOYSA-N 4-bromo-1h-pyrazole-5-carboxylic acid Chemical compound OC(=O)C=1NN=CC=1Br QISOBCMNUJQOJU-UHFFFAOYSA-N 0.000 description 1
- GTOLCXTWQDBGBN-UHFFFAOYSA-N 4-methoxy-10h-benzo[1,2]cyclohepta[3,4-b]thiophene Chemical compound COC1=CC2=CC=CC=C2CC2=C1SC=C2 GTOLCXTWQDBGBN-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Natural products OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229910021627 Tin(IV) chloride Inorganic materials 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 125000001539 acetonyl group Chemical group [H]C([H])([H])C(=O)C([H])([H])* 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- FKPSBYZGRQJIMO-UHFFFAOYSA-M benzyl(triethyl)azanium;hydroxide Chemical compound [OH-].CC[N+](CC)(CC)CC1=CC=CC=C1 FKPSBYZGRQJIMO-UHFFFAOYSA-M 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 150000004292 cyclic ethers Chemical class 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 150000002081 enamines Chemical class 0.000 description 1
- 150000002085 enols Chemical group 0.000 description 1
- 150000002118 epoxides Chemical class 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 125000001033 ether group Chemical group 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-M fumarate(1-) Chemical compound OC(=O)\C=C\C([O-])=O VZCYOOQTPOCHFL-OWOJBTEDSA-M 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 125000000268 heptanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 150000002440 hydroxy compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 239000003176 neuroleptic agent Substances 0.000 description 1
- 230000000701 neuroleptic effect Effects 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229940124531 pharmaceutical excipient Drugs 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 125000000542 sulfonic acid group Chemical group 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- HPGGPRDJHPYFRM-UHFFFAOYSA-J tin(iv) chloride Chemical compound Cl[Sn](Cl)(Cl)Cl HPGGPRDJHPYFRM-UHFFFAOYSA-J 0.000 description 1
- XJDNKRIXUMDJCW-UHFFFAOYSA-J titanium tetrachloride Chemical compound Cl[Ti](Cl)(Cl)Cl XJDNKRIXUMDJCW-UHFFFAOYSA-J 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/78—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
- C07D333/80—Seven-membered rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Description
Fremgangsmåte for fremstilling av nye orga-niske forbindelser. Procedure for the production of new organic compounds.
Foreliggende oppfinnelse vedrører en fremgangsmåte for fremstilling av nye organiske forbindelser med formel I The present invention relates to a method for the production of new organic compounds with formula I
hvori in which
står for hydrogen, en alkylgruppe med 1-6 karbonatomer,stands for hydrogen, an alkyl group with 1-6 carbon atoms,
en cykloalkylgruppe med 4-6 karbonatomer,a cycloalkyl group with 4-6 carbon atoms,
en hydroksyalkylgruppe med 2 til 5 karbonatomer hvis hydroksygruppe er skilt fra nitrogenatomet ved minst to a hydroxyalkyl group of 2 to 5 carbon atoms whose hydroxy group is separated from the nitrogen atom by at least two
karbonatomer, en oksoalkylgruppe med 3 til 5 karbonatomer hvis karbonylgruppe er skilt fra nitrogenatomet ved minst ett karbonatom, en alkanoyloksyalkylgruppe som inneholder en alkanoylrest med 2 til 10 karbonatomer og en oksyalkylrest med 2 til 5 karbonatomer hvis oksygenatom er skilt fra nitrogenatomet ved minst 2 karbonatomer, eller en alkoksykarbonylalkylgruppe som inneholder en alkoksyrest med 1 til 4 karbonatomer og en alkylkarbonylrest med 3 til 6 karbonatomer, hvis karbonylgruppe er skilt fra nitrogenatomet ved minst ett karbonatom, carbon atoms, an oxoalkyl group of 3 to 5 carbon atoms whose carbonyl group is separated from the nitrogen atom by at least one carbon atom, an alkanoyloxyalkyl group containing an alkanoyl radical of 2 to 10 carbon atoms and an oxyalkyl radical of 2 to 5 carbon atoms whose oxygen atom is separated from the nitrogen atom by at least 2 carbon atoms, or an alkoxycarbonylalkyl group containing an alkoxy acid residue of 1 to 4 carbon atoms and an alkylcarbonyl residue of 3 to 6 carbon atoms, whose carbonyl group is separated from the nitrogen atom by at least one carbon atom,
betyr hydrogen, klor eller alkyl med 1-4 karbonatomer. ogmeans hydrogen, chlorine or alkyl of 1-4 carbon atoms. and
R 3 betyr hydrogen, alkyl med 1 til 4 karbonatomer eller halogen R 3 means hydrogen, alkyl with 1 to 4 carbon atoms or halogen
med et atomtall på 17 til 35,with an atomic number of 17 to 35,
idet høyst to av substituentene R^, R2og R^betyr hydrogen,where at most two of the substituents R^, R2 and R^ represent hydrogen,
og syreaddisjonssalter derav.and acid addition salts thereof.
Alkyl- eller alkylengrupper som inneholdes i resten R^kan være rettkjedet eller forgrenet. Alkyl or alkylene groups contained in the residue R^ can be straight-chain or branched.
Hvis R^står for en i det foregående definert alkylgruppe inneholder denne foretrukket 1 til 4, spesielt 1 til 3 karbonatomer og utgjør spesielt metyl, etyl. eller isopropyl. En i resten R^ inneholdt funksjonell gruppe er foretrukket skilt fra nitrogenatomet ved 2 eller 3 karbonatomer. Hvis R^står for en hydroksyalkylgruppe, inneholder denne foretrukket 2 eller 3 karbonatomer. Som eksempel på foretrukne hydroksyalkylgrupper nevnes 2-hydroksyetyl og 3-hydroksypropyl. Hvis R^står for en i det foregående definert oksoalkylgruppe", inneholder denne foretrukket en CH^-CO-gruppe og utgjør f.eks. acetonyl eller 4-oksopentylgruppen. Hvis R^utgjør en alkanoyloksyalkylgruppe inneholder den til nitrogenatomet bundne oksyalkylrest foretrukket 2 eller 3 karbonatomer. Alkanoyl-resten kan f.eks. utgjøre en acetyl- eller heptanoylgruppe. Som eksempel på godt egnede alkanoyloksyalkylgrupper nevnes acetoksyetyl eller heptanoyloksyetyl. Hvis R^utgjør en alkoksykarbonylalkylgruppe inneholder den til nitrogenatomet bundne karbonylalkylrest foretrukket 3 eller 4 karbonatomer. Alkoksyresten utgjør foretrukket metoksy eller etoksy. Som eksempel på egnede alkoksykarbonylalkylgrupper nevnes etoksykarbonyletyl og etoksy-karbonylpropyl. If R^ stands for an alkyl group defined above, this preferably contains 1 to 4, especially 1 to 3 carbon atoms and constitutes especially methyl, ethyl. or isopropyl. A functional group contained in the residue R^ is preferably separated from the nitrogen atom by 2 or 3 carbon atoms. If R^ stands for a hydroxyalkyl group, this preferably contains 2 or 3 carbon atoms. Examples of preferred hydroxyalkyl groups are 2-hydroxyethyl and 3-hydroxypropyl. If R^ stands for a previously defined oxoalkyl group", this preferably contains a CH^-CO group and constitutes, for example, the acetonyl or 4-oxopentyl group. If R^ constitutes an alkanoyloxyalkyl group, the oxyalkyl residue bound to the nitrogen atom preferably contains 2 or 3 carbon atoms. The alkanoyl residue can, for example, constitute an acetyl or heptanoyl group. As examples of well-suited alkanoyloxyalkyl groups, acetoxyethyl or heptanoyloxyethyl are mentioned. If R^ constitutes an alkoxycarbonylalkyl group, the carbonylalkyl residue bonded to the nitrogen atom preferably contains 3 or 4 carbon atoms. methoxy or ethoxy Examples of suitable alkoxycarbonylalkyl groups are ethoxycarbonylethyl and ethoxycarbonylpropyl.
Substituenten R^står foretrukket for en alkylgruppe med 1 tilThe substituent R^ preferably stands for an alkyl group with 1 more
3 karbonatomer eller en hydroksyalkylgruppe med 2 til 3 karbonatomer. 3 carbon atoms or a hydroxyalkyl group of 2 to 3 carbon atoms.
R2betyr foretrukket hydrogen. En slik substituent R^er foretrukket anordnet i 2-stillingen av benzocykloheptatiofenskjelletet. Hvis R2betyr en i det foregående definert alkylgruppe inneholder denne foretrukket 1 til 2 karbonatomer og utgjør spesielt metyl. R2 preferably means hydrogen. Such a substituent R is preferably arranged in the 2-position of the benzocycloheptathiophene shell. If R 2 denotes an alkyl group defined above, this preferably contains 1 to 2 carbon atoms and is especially methyl.
tt
R3betyr foretrukket hydrogen. En slik substituent R 3 er foretrukket anordnet i 6- eller 7-stillingen, spesielt i 7-stillingen av benzocykloheptatiofenskjelletet og utgjør foretrukket klor. Hvis R^står for i det foregående definert alkyl inneholder dette foretrukket 1 til 2 karbonatomer og utgjør spesielt metyl. R3 preferably means hydrogen. Such a substituent R 3 is preferably arranged in the 6- or 7-position, especially in the 7-position of the benzocycloheptathiophene shell and preferably constitutes chlorine. If R^ stands for alkyl as defined above, this preferably contains 1 to 2 carbon atoms and is especially methyl.
Foretrukket er spesielt slike forbindelser med formel I hvori R1betyr en alkylgruppe med 1 til 3 karbonatomer eller en hydroksyalkylgruppe med 2 til 3 karbonatomer, hvis hydroksygruppe er skilt fra nitrogenatomet ved minst to karbonatomer, R2betyr hydrogen og R^står for hydrogen eller klor, som foretrukket er anordnet i 7-stillingen vav ringskjelletet. Particularly preferred are such compounds of formula I in which R1 means an alkyl group with 1 to 3 carbon atoms or a hydroxyalkyl group with 2 to 3 carbon atoms, whose hydroxy group is separated from the nitrogen atom by at least two carbon atoms, R2 means hydrogen and R^ stands for hydrogen or chlorine, as preferred is arranged in the 7-position vav the ring shell.
Det særegne ved fremgangsmåten i henhold til oppfinnelsen for fremstilling av de nye forbindelser med formel I og deres syreaddisjonssalter er at The peculiarity of the method according to the invention for the production of the new compounds of formula I and their acid addition salts is that
a) for fremstilling av forbindelser med formel Iaa) for the preparation of compounds of formula Ia
hvori R2og R^har den ovennevnte betydning og R-^<1>står for hydrogen, en alkylgruppe med 1 til 6 karbonatomer, en cykloalkylgruppe med 4 til 6 karbonatomer, en hydroksyalkylgruppe med 2 til 5 karbonatomer, hvis hydroksygruppe er skilt fra nitrogenatomet ved minst to karbonatomer eller en oksoalkylgruppe med 3 til 5 karbonatomer, hvis karbonylgruppe er skilt fra nitrogenatomet ved minst ett karbonatom, kondenseres forbindelser med formel II wherein R2 and R^ have the above meaning and R-^<1> stands for hydrogen, an alkyl group of 1 to 6 carbon atoms, a cycloalkyl group of 4 to 6 carbon atoms, a hydroxyalkyl group of 2 to 5 carbon atoms, whose hydroxy group is separated from the nitrogen atom by at least two carbon atoms or an oxoalkyl group with 3 to 5 carbon atoms, if the carbonyl group is separated from the nitrogen atom by at least one carbon atom, compounds of formula II are condensed
hvori R 2 og R 3 har den ovennevnte betydning og R^betyr wherein R 2 and R 3 have the above-mentioned meaning and R^means
hydrogen eller lavere alkyl, med forbindelser med formel hydrogen or lower alkyl, with compounds of the formula
III III
hvori R^<1>har den ovennevnte betydning eller wherein R^<1> has the above meaning or
b) for fremstilling av forbindelser med formel Ic . b) for the preparation of compounds of formula Ic.
hvori R2og R^ har den ovennevnte betydning og R^ 11 står for in which R 2 and R 1 have the above meaning and R 11 stands for
en alkylgruppe med 1 til 6 karbonatomer, en cykloalkylgruppe med 4 til 6 karbonatomer, en hydroksyalkylgruppe med 2 til 5 an alkyl group with 1 to 6 carbon atoms, a cycloalkyl group with 4 to 6 carbon atoms, a hydroxyalkyl group with 2 to 5
. karbonatomer, hvis hydroksygruppe er skilt fra nitrogenatomet ved minst to karbonatomer, en oksoalkylgruppe med 3 til 5 karbonatomer, hvis karbonylgruppe er skilt fra nitrogenatomet ved . carbon atoms, whose hydroxy group is separated from the nitrogen atom by at least two carbon atoms, an oxoalkyl group with 3 to 5 carbon atoms, whose carbonyl group is separated from the nitrogen atom by
minst ett karbonatom, eller en alkoksykarbonylalkylgruppe, som inneholder en alkoksyrest med 1 til 4 karbonatomer eller en karbonylalkylrest med 3 til 6 karbonatomer, hvis karbonylgruppe er skilt fra nitrogenatomet ved minst ett karbonatom, at least one carbon atom, or an alkoxycarbonylalkyl group, which contains an alkoxy acid residue with 1 to 4 carbon atoms or a carbonylalkyl residue with 3 to 6 carbon atoms, whose carbonyl group is separated from the nitrogen atom by at least one carbon atom,
alkyleres forbindelser med formel Ibcompounds of formula Ib are alkylated
hvori R ? og R-, har den ovennevnte betydning, eller c) for fremstilling av forbindelser med formel le hvori R2og R^har den ovennevnte betydning, A betyr en alkylengruppe med 2 til 5 karbonatomer og R^står for en alkylgruppe med 1 til 9 karbonatomer, acyleres forbindelser med formel Id where R ? and R-, has the above-mentioned meaning, or c) for the preparation of compounds of formula le in which R2 and R^ have the above-mentioned meaning, A means an alkylene group with 2 to 5 carbon atoms and R^ stands for an alkyl group with 1 to 9 carbon atoms, compounds of formula Id are acylated
hvori I^/R 3 og A har den ovennevnte betydning, wherein I^/R 3 and A has the above meaning,
og de erholdte forbindelser med formel I overføres eventuelt i sine syreaddisjonssalter. and the obtained compounds of formula I are optionally transferred in their acid addition salts.
Kondensasjonsreaksjonen for forbindelsene med formel II med forbindelsene med formel III kan skje på i og for seg kjente måter i nærvær av et vann- eller alkoholavspaltende middel. Forbindelsene med formel II, hvori R. betyr hydrogen, kan anvendes i enolformen eller den dertil isomere ketoform. Som vann- eller alkoholavspaltende middel egner seg for eksempel Lewis-syrer eller foretrukket sterke uorganiske eller organiske syrer. Hvis reaksjonen foretas i nærvær av en sterk uorganisk eller organisk syre, The condensation reaction of the compounds of formula II with the compounds of formula III can take place in ways known per se in the presence of a water or alcohol splitting agent. The compounds of formula II, in which R. means hydrogen, can be used in the enol form or the keto form isomeric to it. Lewis acids or preferably strong inorganic or organic acids are suitable as water- or alcohol-releasing agents. If the reaction is carried out in the presence of a strong inorganic or organic acid,
anvendes foretrukket ekvivalente mengder av disse syrer og reaksjonen gjennomføres ved forhøyet temperatur, foretrukket ved temperaturer mellom 50 og 250°G. Som eksempel på egnede syrer nevnes mineralsyrer som svovelsyre eller organiske syrer som benzensulfonsyre eller p-toluénsulfonsyre. Vann eller alkohol, som dannes ved reaksjonen, kan fjernes direkte under reaksjonen ved destillasjon, foretrukket under redusert trykk, f.eks. et trykk mellom 10 og 100 torr. equivalent amounts of these acids are preferably used and the reaction is carried out at an elevated temperature, preferably at temperatures between 50 and 250°G. Examples of suitable acids include mineral acids such as sulfuric acid or organic acids such as benzenesulfonic acid or p-toluenesulfonic acid. Water or alcohol, which is formed during the reaction, can be removed directly during the reaction by distillation, preferably under reduced pressure, e.g. a pressure between 10 and 100 torr.
Etter en hensiktsmessig utførelsesform sammensmeltes f.eks. et vannfritt salt, f.eks. p-toluensulfonatet av en forbindelse med formel III med en forbindelse med formel II og blandingen oppvarmes foretrukket under redusert trykk. Reaksjonstemperaturen utgjør hvis R4betyr hydrogen foretrukket mellom 150 og 250°C, og hvis R4betyr lavere alkyl, foretrukket mellom 100 og 200°C. Hvis reaksjonen skjer i nærvær av en Lewis-syre gjennomføres den i et under reaksjonsbetingelsene inert organisk løsningsmiddel, f.eks. According to an appropriate embodiment, e.g. an anhydrous salt, e.g. the p-toluenesulfonate of a compound of formula III with a compound of formula II and the mixture is preferably heated under reduced pressure. The reaction temperature is, if R4 means hydrogen, preferably between 150 and 250°C, and if R4 means lower alkyl, preferably between 100 and 200°C. If the reaction takes place in the presence of a Lewis acid, it is carried out in an organic solvent that is inert under the reaction conditions, e.g.
et aromatisk hydrokarbon som benzen ved forhøyet temperatur, foretrukk< an aromatic hydrocarbon such as benzene at elevated temperature is preferred
ved koketemperaturen for reaksjonsblandingen. Som Lewis-syrer anvendes foretrukket'titantetraklorid eller tinntetraklorid. at the boiling temperature of the reaction mixture. Titanium tetrachloride or tin tetrachloride are preferably used as Lewis acids.
Alkyleringen av forbindelsene med 'formel Ib i henhold til fremgangsmåtevariant b) kan gjennomføres på for alkylering av sekundære aminer i og for seg vanlige måter, f.eks. kan forbindelsene med formel Ib på i og for seg kjent måte omsettes med forbindelser med formel IV The alkylation of the compounds of formula Ib according to process variant b) can be carried out in ways customary for the alkylation of secondary amines per se, e.g. the compounds of formula Ib can be reacted with compounds of formula IV in a manner known per se
hvori R-^<11>har den ovennevnte betydning og X står for syreresten av en reaksjonsdyktig ester, foretrukk±. for halogen eller en organisk sulfonsyrerest. Omsetningen skjer foretrukket i et under reaksjonsbetingelsene inert organisk løsningsmiddel ved temperaturer mellom ca. 20°C og koketemperaturen for reaksjonsblandingen, foretrukket i nærvær av et basisk kondensasjonsmiddel, f.eks. et organisk amin som trietylamin eller et alkalimetallkarbonat, wherein R-^<11> has the above meaning and X stands for the acid residue of a reactive ester, preferably ±. for halogen or an organic sulfonic acid residue. The reaction preferably takes place in an organic solvent inert under the reaction conditions at temperatures between approx. 20°C and the boiling temperature of the reaction mixture, preferably in the presence of a basic condensing agent, e.g. an organic amine such as triethylamine or an alkali metal carbonate,
eller i nærvær av et overskudd av en forbindelse med formel Ib. Som løsningsmiddel egner seg f.eks. lavere alkoholer, halogenerte hydrokarboner eller dimetylformamid. Forbindelser, med formel Ic , som ikke inneholder noen grupper som kan reduseres ved mild katalytisk hydrogenering og hvori det til det karbonatom i resten som befinner seg. i .; ^--stillingen til nitrogenatomet er bundet minst ett hydrogenatom, kan også erholdes ved reduserende or in the presence of an excess of a compound of formula Ib. As a solvent, e.g. lower alcohols, halogenated hydrocarbons or dimethylformamide. Compounds, of formula Ic, which do not contain any groups which can be reduced by mild catalytic hydrogenation and in which to the carbon atom of the residue which is present. in .; The ^- position to which the nitrogen atom is bound at least one hydrogen atom can also be obtained by reduction
alkylering. Den reduserende alkylering, som spesielt er egnet foralkylation. The reductive alkylation, which is particularly suitable for
v fremstilling av forbindelser med formel Ic, hvori R^<11>betyr cykloalkyl med 4 til 6 karbonatomer, skjer ved reduserende omsetning med et tilsvarende aldehyd eller keton. Den reduserende alkylering kan skje ved katalytisk hydrogenering under milde reaksjonsbetingelser, foretrukket i nærvær av en palladiumkatalysator, f.eks. palladium/kull (5 eller 10%) eller palladium/bariumsulfat. Som løsningsmiddel egner seg f.eks. lavere alkoholer som etanol eller dimetylformamid. For fremstilling av forbindelse med formel Ic, hvori R^<11>står for en i det foregående definert alkoksykarbonylalkylgruppe, hvis karbonylgruppe er skilt fra nitrogenatomet ved minst 2 karbonatomer, gjennomføres alkyleringen foretrukket ved addisjon av tilsvarende akrylsyrederivater etter metoden til Michael. Miehael-addisjonen av akrylsyrederivater til forbindelser v production of compounds of formula Ic, in which R^<11>means cycloalkyl with 4 to 6 carbon atoms, takes place by reductive reaction with a corresponding aldehyde or ketone. The reductive alkylation can take place by catalytic hydrogenation under mild reaction conditions, preferably in the presence of a palladium catalyst, e.g. palladium/charcoal (5 or 10%) or palladium/barium sulfate. As a solvent, e.g. lower alcohols such as ethanol or dimethylformamide. For the preparation of compound of formula Ic, in which R^<11> stands for a previously defined alkoxycarbonylalkyl group, whose carbonyl group is separated from the nitrogen atom by at least 2 carbon atoms, the alkylation is preferably carried out by addition of corresponding acrylic acid derivatives according to the method of Michael. The Miehael addition of acrylic acid derivatives to compounds
med formel Ib kan gjennomføres på i og for seg kjent måte i et under reaksjonsbetingelsene inert organisk løsningsmiddel, foretrukket en eyklisk eter som dioksan, foretrukket i nærvær av en basisk katalysator, f.eks. et organisk ammoniumhydroksyd som benzyltrietylammoniumhydroksyd. Reaksjonstemperaturen kan ligge mellom romtemperaturen og koketemperaturen for reaksjonsblandingen, foretrukket mellom 40 og 50°C. For fremstilling av forbindelser med formel le, hvori R-^11 står for en i det foregående definert hydroksyalkylgruppe, hvis hydroksygruppe er skilt fra nitrogenatomet med minst to karbonatomer, kan forbindelsene med formel Ib også på i og for seg kjent måte-omsettes med tilsvarende epoksyder. with formula Ib can be carried out in a manner known per se in an organic solvent inert under the reaction conditions, preferably a cyclic ether such as dioxane, preferably in the presence of a basic catalyst, e.g. an organic ammonium hydroxide such as benzyltriethylammonium hydroxide. The reaction temperature can lie between room temperature and the boiling temperature of the reaction mixture, preferably between 40 and 50°C. For the preparation of compounds of formula le, in which R-^11 stands for a hydroxyalkyl group defined above, whose hydroxy group is separated from the nitrogen atom by at least two carbon atoms, the compounds of formula Ib can also be reacted in a manner known per se with corresponding epoxides.
Acyleringen av forbindelsene med formel Id i henhold til fremgangsmåtevariant e) kan skje etter i og for seg kjente metoder, f.eks. ved omsetning med tilsvarende syrehalogenider, foretrukket klorider, eller tilsvarende syreahhydrider. Hvis det som acyleringsmiddel anvendes syreanhydrider, gjennomføres omsetningen under milde reaksjonsbetingelser, f.eks. ved temperaturer mellom -10 og 50, foretrukket mellom 0 og 10°C. Ved anvendelse av syrehalogenider som acyleringsmiddel gjennomføres reaksjonen foretrukket i nærvær av et syrebindende middel, f.eks. en organisk base som pyrridin, eventuelt under tilsetning av et under reaksjonsbetingelsene inert organisk løsningsmiddel. pH-verdien for reaksjonsblandingen ligger foretrukket mellom 5 og 14, spesielt mellom 7 og 8. The acylation of the compounds of formula Id according to process variant e) can take place according to methods known per se, e.g. by reaction with corresponding acid halides, preferably chlorides, or corresponding acid anhydrides. If acid anhydrides are used as acylating agent, the reaction is carried out under mild reaction conditions, e.g. at temperatures between -10 and 50, preferably between 0 and 10°C. When using acid halides as acylating agent, the reaction is preferably carried out in the presence of an acid binding agent, e.g. an organic base such as pyridine, optionally with the addition of an organic solvent inert under the reaction conditions. The pH value for the reaction mixture is preferably between 5 and 14, especially between 7 and 8.
De ved fremgangsmåten i henhold til oppfinnelsen érholdbare forbindelser med formel I kan foreligge i form av de fri- baser eller deres syreaddisjonssalter. De fri baser kan på i og for seg kjent måte overføres i sine syreaddisjonssalter og omvendt. Således kan forbindelsene med formel I f.eks. med uorganiske syrer som saltsyre eller med organiske syrer som fumar- eller maleinsyre danne syreaddisjonssalter. Da enaminer kan spaltes i vandig medium ved et overskudd av protoner, utvinnes syreaddisjonssaltene av forbindelsene med formel I foretrukket i vannfritt medium under The compounds of formula I which can be preserved by the method according to the invention can be in the form of the free bases or their acid addition salts. The free bases can be transferred in a manner known per se into their acid addition salts and vice versa. Thus, the compounds of formula I can e.g. with inorganic acids such as hydrochloric acid or with organic acids such as fumaric or maleic acid to form acid addition salts. As enamines can be cleaved in an aqueous medium by an excess of protons, the acid addition salts of the compounds of formula I are preferably recovered in an anhydrous medium under
•anvendelse av ekvivalente mengder syre.•use of equivalent amounts of acid.
Utgangsforbindelsene kan erholdes på følgende måte: The output connections can be obtained in the following way:
a<1>) forbindelsen med formel Ilaa<1>) the compound of formula IIa
hvori og har den ovennevnte betydning, kan f .eks. fremstilles ved at etergruppene i forbindelser med formel Hb hvori R2og R^har den ovennevnte betydning og R^1 betyr lavere alkyl, på i og for seg kjent måte overføres i hydroksy-grupper. De erholdte forbindelser med formel Ila foreligger vanlig.delvis i deres ketoform. b') forbindelser med formel. Ilb kan f.eks. erholdes ved at forbindelser med formel V hvori og og R^<1>har den ovennevnte betydning, reduseres. Reduksjonen kan f.eks. foretas ved hjelp av en blanding av aluminiumklorid og litiumaluminiumhydrid i et under reaksjonsbetingelsene inert organisk løsningsmiddel. c') forbindelser med formel V, kan erholdes på i og for seg kjent måte, ved at forbindelser med formel VI in which and has the above meaning, can e.g. is produced by the ether groups in compounds of formula Hb in which R2 and R^ have the above meaning and R^1 means lower alkyl, in a manner known per se, is transferred into hydroxy groups. The obtained compounds of formula IIa usually exist partly in their keto form. b') compounds with formula Ilb can e.g. is obtained by reducing compounds of formula V in which and and R^<1> have the above-mentioned meaning. The reduction can e.g. is carried out using a mixture of aluminum chloride and lithium aluminum hydride in an organic solvent that is inert under the reaction conditions. c') compounds of formula V can be obtained in a manner known per se, in that compounds of formula VI
hvori R2og R^har den ovennevnte betydning, bromeres ved hjelp av N-bromsuccinimid, de erholdte i 9- og 10-stillingen av ringskjeHetet dibromerte reaksjonsprodukter omsettes med in which R 2 and R 2 have the above meaning, are brominated using N-bromosuccinimide, the dibrominated reaction products obtained in the 9- and 10-positions of the ring reaction are reacted with
en alkohol med formel R^OH, hvori R^1 har den ovennevnte betydning og deretter avspaltes bromhydrogensyre. an alcohol with the formula R^OH, in which R^1 has the above meaning and hydrobromic acid is then split off.
d<1->) forbindelser med formel VI kan erholdes på i og for seg kjent måte, f.eks. analogt med den i Heiv. Chim. Aeta 49, 214-234 (1966) beskrevne fremgangsmåte, ved å gå ut fra tilsvarende 2-/ 2-(2-tienyl)etyl7benzosyrederivater. d<1->) compounds of formula VI can be obtained in a manner known per se, e.g. analogous to the one in Heiv. Chim. Aeta 49, 214-234 (1966) described method, starting from corresponding 2-/2-(2-thienyl)ethyl7benzoic acid derivatives.
I den utstrekning fremstillingen av utgangsforbindelsene ikke er beskrevet er disse kjente eller kan fremstilles etter i og for seg kjente metoder henholdsvis analogt med de her beskrevne eller analogt med i og for seg kjente metoder. To the extent that the production of the starting compounds is not described, these are known or can be produced according to per se known methods, respectively analogous to those described here or analogous to per se known methods.
Forbindelsene med formel I og deres fysiologisk tålbare syre-addis jonssalter utmerker seg ved interessante farmakologiske egenskaper og kan følgelig anvendes som legemiddel. The compounds of formula I and their physiologically tolerable acid addition salts are distinguished by interesting pharmacological properties and can consequently be used as pharmaceuticals.
Således viser forbindelsene ved dyreforsøk for nevroleptika typiske egenskaper og hemmer f.eks. den spontane motilitet av mus. Thus, in animal experiments for neuroleptics, the compounds show typical properties and inhibit e.g. the spontaneous motility of mice.
På grunn av de nevnte virkninger kan forbindelsene med formelDue to the aforementioned effects, the compounds of formula
I finne anvendelse som neuroleptika og anvendes i psykiatrienIn finding use as a neuroleptic and used in psychiatry
for behandling av psykotiske forstyrrelser.for the treatment of psychotic disorders.
Som legemiddel kan forbindelsene med formel I og deres fysiologisk tålbare syreaddisjonssalter inneholdes sammen med vanlige farmasøytiske hjelpestoffer i galeniske preparater som f.eks. tabletter, kapsler eller løsninger. Disse galeniske preparater kan fremstilles etter i og for seg kjente metoder. As drugs, the compounds of formula I and their physiologically tolerable acid addition salts can be contained together with common pharmaceutical excipients in galenic preparations such as e.g. tablets, capsules or solutions. These galenic preparations can be prepared according to methods known per se.
I de etterfølgende eksempler som illustrerer oppfinnelsen, erIn the following examples which illustrate the invention,
alle temperaturangivelser i °C.all temperature indications in °C.
Eksempel 1; lziå^ Z^^ 2^ j.^ £Y] Sl2h^ l2t:^^ j. 2z& t:i2t.^ zlL9. ZYllExample 1; lziå^ Z^^ 2^ j.^ £Y] Sl2h^ l2t:^^ j. 2z& t:i2t.^ zlL9. ZYll
.43 g N-metylpiperazin i 100 ml metanol tilsettes en løsning av 83.0 g p-toluensulfonsyremonohydrat i 250 ml metanol, inndampes under redusert trykk og inndampningsresten tørres under vannstrålevakuum (ca. 15 torr) i 1 .time ved 150°C. Det erholdte tosylat pulveriseres etter avkjøling, blandes med 50.v6)g 10-metoksy-4-H-benzo/4",5J7-cyklohepta/1,2-b7tiofen og oppvarmes i 30 minutter ved 160°C og deretter i 1.5 time under redusert trykk (ca. 15 torr) ved 160°C. Etter avkjøling til romtemperatur tilsettes den faste reaksjons-blanding 250 ml kloroform og 250 ml 20% NaOH, kloroformfasen fraskilles og den vandige løsning ekstraheres videre med kloroform. De forenede organiske løsninger vaskes med vann, tørres over kaliumkarbonat og inndampes. Den erholdte rå i overskriften nevnte forbindelse omkrystalliseres fra isopropanol. Smp. 147 - 151°C. .43 g of N-methylpiperazine in 100 ml of methanol is added to a solution of 83.0 g of p-toluenesulfonic acid monohydrate in 250 ml of methanol, evaporated under reduced pressure and the evaporation residue is dried under a water jet vacuum (approx. 15 torr) for 1 hour at 150°C. The tosylate obtained is pulverized after cooling, mixed with 50.v6)g of 10-methoxy-4-H-benzo/4",5J7-cyclohepta/1,2-b7thiophene and heated for 30 minutes at 160°C and then for 1.5 hours under reduced pressure (approx. 15 torr) at 160° C. After cooling to room temperature, 250 ml of chloroform and 250 ml of 20% NaOH are added to the solid reaction mixture, the chloroform phase is separated and the aqueous solution is further extracted with chloroform. The combined organic solutions are washed with water, dried over potassium carbonate and evaporated. The obtained crude title compound is recrystallized from isopropanol. M.P. 147 - 151°C.
Utgangsmaterialet erholdes på følgende måte:The starting material is obtained in the following way:
a) til en blanding av 300 ml abs. eter, 28.9 g vannfritt aluminiumklorid og 7.2 g litiumaluminiumhydrid tilsettes iløpet av a) to a mixture of 300 ml abs. ether, 28.9 g of anhydrous aluminum chloride and 7.2 g of lithium aluminum hydride are added during
20 minutter ved 20 r- 25°G porsjonsvis 30 g 10-metoksy-4H-benzo/4 , SjTcyklohepta/C 2-b_7tiof en-4-on og det omrøres deretter i 1 time ved romtemperatur. Deretter tildryppes ved 20°C 20 minutes at 20 r- 25°G in portions 30 g of 10-methoxy-4H-benzo/4,SjTcyclohepta/C 2-b_7thiophen-4-one and it is then stirred for 1 hour at room temperature. It is then added drop by drop at 20°C
under avkjøling 300 ml etylacetat og deretter 150 ml 25%while cooling 300 ml ethyl acetate and then 150 ml 25%
NaOH. Den organiske fase avdekanteres fra den bløte masse av uorganisk material og inndampes. Inndampningsresten omkrystalliseres fra metanol. På denne måte erholdes 10-metoksy-4H-benzo/4 , 5_7cyklohepta/l, 2-bJ^tiof en. NaOH. The organic phase is decanted from the soft mass of inorganic material and evaporated. The evaporation residue is recrystallized from methanol. In this way, 10-methoxy-4H-benzo[4,5]cyclohepta[1,2-b]thiophene is obtained.
Smp. 94 til 96°C.Temp. 94 to 96°C.
Eksempel 2: lii^H-b^nzo^ASZcyk^oheptaExample 2: lii^H-b^nzo^ASZcyk^ohepta
10 g 4H-benzoZ4",57cykloheptaZl,2-b7tiofen-10 (9H)-on, 41.3 g N-metylpiperazin og 200 ml benzen anordnes i en kolbe og tilsettes 78.5 g p-toluensulfonsyremonohydrat.. Suspensjonen inndampes deretter i vakuum og inndampningsresten oppvarmes i 5 timer ved 200°C oljebadtemperatur under vannstrålevakuum (15 torr). Etter avkjøling til ca. 50°C tilsettes reaksjonsblandingen 300 ml 3N NaOH og 500 ml benzen og oppløses under omrøring. Den organiske fase fraskilles deretter, vaskes med vann, tørres over natrium-sulfat og inndampes. På denne måte erholdes den rå i overskriften nevnte forbindelse (base) som etter omkrystallisering fra isopropanol smelter ved 147 til 151°C. 10 g of 4H-benzoZ4",57cycloheptaZl,2-b7thiophen-10 (9H)-one, 41.3 g of N-methylpiperazine and 200 ml of benzene are placed in a flask and 78.5 g of p-toluenesulfonic acid monohydrate are added. The suspension is then evaporated in vacuo and the evaporation residue is heated for 5 hours at 200°C oil bath temperature under water jet vacuum (15 torr). After cooling to about 50°C, 300 ml of 3N NaOH and 500 ml of benzene are added to the reaction mixture and dissolved with stirring. The organic phase is then separated, washed with water, dried over sodium sulfate and evaporated.In this way, the crude compound mentioned in the title (base) is obtained which, after recrystallization from isopropanol, melts at 147 to 151°C.
Utgangsmaterialet erholdes på følgende måte:The starting material is obtained in the following way:
a) 32.75 g 10-metoksy-4H-benzo/5 , 5_7cyklohepta/T, 2-b7tiof en kokes under tilakeløp i 1 time i 300 ml N saltsyre og 300 ml a) 32.75 g of 10-methoxy-4H-benzo/5,5_7cyclohepta/T,2-b7thiophene are boiled under reflux for 1 hour in 300 ml N hydrochloric acid and 300 ml
metanol. Deretter avkjøles og produktet frafiltreres. Krystallisatet omkrystalliseres fra isopropanol. På denne måte erholdes det rene 4H-benzo/4 , 5_7cyklohepta/l, 2-b_7tiof en-10 (9H) -on som smelter ved 117 til 119°C. methanol. It is then cooled and the product is filtered off. The crystallisate is recrystallized from isopropanol. In this way, pure 4H-benzo[4,5-7cyclohepta[1,2-b]thiophene-10 (9H)-one is obtained which melts at 117 to 119°C.
Analogt med eksempel 1 og 2 kan også de følgende forbindelserAnalogously to examples 1 and 2, the following compounds can also
med formel Ia erholdes ved omsetning av tilsvarende piperaz-in-derivater med formel III med tilsvarende 4H-benzo,/3 , 5j7cyklohepta/1,2-bi tiofenderivater med formel II with formula Ia is obtained by reaction of corresponding piperazin derivatives with formula III with corresponding 4H-benzo,/3,5j7cyclohepta/1,2-bithiophene derivatives with formula II
Eksempel 3: 4 = 14H-benzo/li5ZcYklohep.ta/Ii2-b Example 3: 4 = 14H-benzo/li5ZcYklohep.ta/Ii2-b
Til suspensjonen av 8.0 g 1-(4H-benzo/3,57cyklohepta/l,2-b7tiofen-10-yl)-piperazin (for fremstillingen se eksempel 1) og 2.6 g natrium-bikarbonat i 20 ml etanol tildryppes,iløpet av 30 minutter en løsning av 3.3 g isopropylbromid i 5 ml etanol ved romtemperatur, reaksjonsblandingen oppvarmes i 4.5 timer ved koketemperatur og inndampes under redusert trykk. Resten løses i 100 ml vann og 300 ml metylenklorid, den organiske fase fraskilles, vaskes med vann og mettet natriumkloridløsning, tørres over magnesiumsulfat To the suspension of 8.0 g of 1-(4H-benzo/3,57cyclohepta/1,2-b7thiophen-10-yl)-piperazine (for the preparation see example 1) and 2.6 g of sodium bicarbonate in 20 ml of ethanol are added dropwise, over 30 minutes a solution of 3.3 g of isopropyl bromide in 5 ml of ethanol at room temperature, the reaction mixture is heated for 4.5 hours at boiling temperature and evaporated under reduced pressure. The residue is dissolved in 100 ml of water and 300 ml of methylene chloride, the organic phase is separated, washed with water and saturated sodium chloride solution, dried over magnesium sulphate
og inndampes. Den erholdte i overskriften nevnte forbindelse overføres i metanol til sitt hydrogenfumarat. Smp.: Spalting and evaporated. The compound obtained in the title is transferred in methanol to its hydrogen fumarate. Smp.: Cleavage
fra 226°G (fra metanol).from 226°G (from methanol).
Analogt med eksempel 3 kan også de i eksempel 2 og i eksempleneAnalogous to example 3, those in example 2 and in the examples can also
2 C til 2 L nevnte forbindelser med formel Ic erholdes ved alkylering av tilsvarende 4-(4H-benzo/3 , 5_7cyklohepta/1, 2-b7tiof en-10-yl)piperazinderivater med formel Ib. 2 C to 2 L said compounds of formula Ic are obtained by alkylation of corresponding 4-(4H-benzo[3,5-7cyclohepta]1,2-b7thiophen-10-yl)piperazine derivatives of formula Ib.
Eksempel 4: lzi2^ l2IZ^ Z^^^ 2/^ j.^ 22Y} Sl2\ l§^^/ Åj. 2:Z^ 7z^ i2i§Uzl9. Z Example 4: lzi2^ l2IZ^ Z^^^ 2/^ j.^ 22Y} Sl2\ l§^^/ Åj. 2:Z^ 7z^ i2i§Uzl9. Z
<yl>)_<->4-CYklopentYlpiperazin. <yl>)_<->4-CYclopentylpiperazine.
En løsning av 6.0 g 1- (7-klor-4H-benzo/4", 57cyklohepta/1, 2-£i7-tiofen-10-yl)piperazin og 1.8 g cyklopentanon i 75 ml etanol hydrogeneres i nærvær av 0.5 g 10% palladium på kull ved 50°C og 5 ato hydrogentrykk. Etter opptagelse av den teoretiske mengde hydrogen (tid ca. 5 timer) frafiltreres katalysatoren, løsningen inndampes til tørrhet og den som fast rest tilbakeblivende i overskriften nevnte forbindelse krystalliseres fra eter. A solution of 6.0 g of 1-(7-chloro-4H-benzo[4",57cyclohepta[1,2-£i7-thiophen-10-yl)piperazine and 1.8 g of cyclopentanone in 75 ml of ethanol is hydrogenated in the presence of 0.5 g of 10 % palladium on charcoal at 50° C and 5 ato hydrogen pressure. After absorption of the theoretical amount of hydrogen (time approx. 5 hours) the catalyst is filtered off, the solution is evaporated to dryness and the compound mentioned in the title remaining as a solid residue is crystallized from ether.
Smp. 169 - 170°C. Temp. 169 - 170°C.
Analogt med eksempel 4 kan også spesielt de i eksemplene 2 A og 2 I nevnte forbindelser med formel Ic erholdes ved reduserende alkylering av tilsvarende 4- (4H-benzo</>4, 5_7cykloheptaZ<T>, 2-b7-tiofen-10-yl)piperazinderivater med formel Ib. Analogous to example 4, especially the compounds of formula Ic mentioned in examples 2 A and 2 I can also be obtained by reductive alkylation of the corresponding 4-(4H-benzo</>4, 5_7cycloheptaZ<T>, 2-b7-thiophene-10- yl)piperazine derivatives of formula Ib.
Eksempel 5: l-^2-acetoksY§tyl]_-4-^4H-benzo^ Example 5: 1-2-acetoxyethyl]-4-4H-benzo
tiofen^lO^YiiPiES^Szinthiophene^lO^YiiPiES^Szin
Til løsningen av 2.0 g 4-(4H-benzo/4",57cyklohepta/I,2-b7tiofen-10-yl)-1-piperazinetanol i 20 ml vannfritt pyridin tildryppes ved romtemperatur 0.48 g acetylklorid, reaksjonsblandingen omrøres videre i 6 timer ved romtemperatur og uthelles på 100 ml vann. To the solution of 2.0 g of 4-(4H-benzo/4",57cyclohepta/1,2-b7thiophen-10-yl)-1-piperazineethanol in 20 ml of anhydrous pyridine is added dropwise at room temperature 0.48 g of acetyl chloride, the reaction mixture is further stirred for 6 hours at room temperature and poured into 100 ml of water.
Den erholdte løsning ekstraheres med benzen, benzenløsningen vaskes med vann, tørres over magnesiumsulfat og inndampes. Den i overskriften nevnte forbindelse krystalliseres fra den erholdte rest av eter/petroleter. Smp. 14 0 til 141°C. The resulting solution is extracted with benzene, the benzene solution is washed with water, dried over magnesium sulphate and evaporated. The compound mentioned in the title is crystallized from the obtained residue of ether/petroleum ether. Temp. 14 0 to 141°C.
Analogt med eksempel 5 kan også de følgende forbindelser med formel le erholdes ved aeylering av den tilsvarende hydroksy-forbindelse med formel Id med det tilsvarende syrederivat. Analogous to example 5, the following compounds of formula le can also be obtained by aylation of the corresponding hydroxy compound of formula Id with the corresponding acid derivative.
Claims (1)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH16475 | 1975-01-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
NO754417L true NO754417L (en) | 1976-07-09 |
Family
ID=4180714
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO754417A NO754417L (en) | 1975-01-08 | 1975-12-30 |
Country Status (13)
Country | Link |
---|---|
JP (1) | JPS5191276A (en) |
BE (1) | BE837345A (en) |
DD (1) | DD123747A5 (en) |
DE (1) | DE2557946A1 (en) |
DK (1) | DK596175A (en) |
FI (1) | FI753694A (en) |
FR (1) | FR2297047A1 (en) |
IL (1) | IL48795A0 (en) |
NL (1) | NL7600001A (en) |
NO (1) | NO754417L (en) |
PT (1) | PT64677B (en) |
SE (1) | SE7514787L (en) |
ZA (1) | ZA76103B (en) |
-
1975
- 1975-12-22 DE DE19752557946 patent/DE2557946A1/en active Pending
- 1975-12-30 DK DK596175A patent/DK596175A/en unknown
- 1975-12-30 NO NO754417A patent/NO754417L/no unknown
- 1975-12-30 FI FI753694A patent/FI753694A/fi not_active Application Discontinuation
- 1975-12-30 SE SE7514787A patent/SE7514787L/en unknown
-
1976
- 1976-01-02 NL NL7600001A patent/NL7600001A/en unknown
- 1976-01-06 DD DD190704A patent/DD123747A5/xx unknown
- 1976-01-06 IL IL48795A patent/IL48795A0/en unknown
- 1976-01-06 BE BE163343A patent/BE837345A/en unknown
- 1976-01-06 FR FR7600133A patent/FR2297047A1/en active Pending
- 1976-01-07 JP JP51000959A patent/JPS5191276A/ja active Pending
- 1976-01-07 PT PT64677A patent/PT64677B/en unknown
- 1976-01-08 ZA ZA760103A patent/ZA76103B/en unknown
Also Published As
Publication number | Publication date |
---|---|
DK596175A (en) | 1976-07-09 |
DD123747A5 (en) | 1977-01-12 |
NL7600001A (en) | 1976-07-12 |
FR2297047A1 (en) | 1976-08-06 |
PT64677B (en) | 1977-08-09 |
FI753694A (en) | 1976-07-09 |
BE837345A (en) | 1976-07-06 |
IL48795A0 (en) | 1976-03-31 |
SE7514787L (en) | 1976-07-09 |
DE2557946A1 (en) | 1976-07-15 |
ZA76103B (en) | 1977-08-31 |
JPS5191276A (en) | 1976-08-10 |
PT64677A (en) | 1976-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US2985657A (en) | 1-(aroylalkyl)-4-heterocyclylpiperazines | |
CA1119601A (en) | Tetrahydropyridine and piperidine derivatives and their acid addition salts, processes for their preparation and pharmaceutical preparations containing such compounds | |
US5403842A (en) | Benzopyran and benzothiopyran derivatives | |
NO174506B (en) | Analogous procedure for the preparation of therapeutically active compounds | |
NO167947B (en) | TAPE OR PLATE RECORDING STORAGE DEVICE | |
NO118710B (en) | ||
NO162176B (en) | AGENTS TO COMPLETE PLANT DISEASES AND USE THEREOF. | |
US3600394A (en) | 2-aminoalkyl-3-arylisocarbostyrils | |
US4216216A (en) | Aromatic piperazinyl substituted dihydrouracils | |
AU616656B2 (en) | Psychotropic bicyclic imides | |
US3705907A (en) | 4-(2-hydroxy)-3-aminopropoxy)-indole derivatives | |
US5852019A (en) | Pyrimidinylpyrazole derivatives | |
NO803453L (en) | PROCEDURE FOR THE PREPARATION OF PIPERIDYLBENZIMIDAZOLONE DERIVATIVES | |
IE871694L (en) | Pyridine derivatives and related intermediates | |
SUGIHARA et al. | 1, 5-Benzoxathiepin Derivatives. II. Synthesis and Serotonin S2-Receptor-Blocking Activity of Aminoalkyl-Substituted 3, 4-Dihydro-2H-1, 5-benzoxathiepin-3-ols and Related Compounds | |
US2852520A (en) | Trialkoxybenzoyloxyalkyl derivatives related to norharman | |
CS207619B2 (en) | Method of making the new derivatives of 5,11-dihydro-6h-pyrido 2,3-b 1,4 benzodiazepin-6-on | |
US3112310A (en) | 10-alkylaminoalkylphenothiazine-2-carboxamides | |
NL7906823A (en) | AUR DERIVATIVES, METHOD FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL PREPARATION WITH ANY OF THESE COMPOUNDS AS THE ACTIVE INGREDIENT. | |
US4144337A (en) | 1,4-Substituted piperazinyl derivatives useful as psychostimulants | |
US2355659A (en) | Piperidine derivatives and process for the manufacture of the same | |
NO145841B (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 2,3-SUBSTITUTED, 5,6-CONDENSED 4 (2H) -AMINOALCOXY-PYRANONES WITH HYPOTENSIVE, ANTI-ISCHAEMIA AND ANTI-HOST EFFECTS | |
HU187572B (en) | Process for preparing 1,5-diphenyl-pyrazolin-3-one derivatives | |
NO754417L (en) | ||
US3040031A (en) | N-heterocyclic compounds |